Phase 4 Cardiomyopathy Trial, Recruiting (NCT06964464)

Phase 4 Cardiomyopathy Trial, Recruiting NCT06964464 Sponsor: University of Rochester Condition: Cardiomyopathy

Printed from Voxsanity (voxsanity.com.au) — NCT06964464 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cardiomyopathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You have an implanted defibrillator device (ICD) that was placed to prevent a first serious heart event, due to heart failure with reduced pumping ability, and your device can be monitored remotely
You are currently taking a heart medication called metoprolol succinate and are willing to switch to a different heart medication called carvedilol
A heart scan in the last 12 months has shown that your heart's pumping function is below 50%

Who may not be able to join:

You are unwilling or unable to follow the study requirements and schedule
You are currently taking a different beta-blocker heart medication other than metoprolol succinate, or you are not taking any beta-blocker medication at all
You have had a bad reaction to carvedilol in the past, or there is a medical reason why you cannot take it
Your blood pressure is too low (the lower number on a blood pressure reading is below 100) (confirm with trial site)
You are already taking part in another clinical trial
You are unable or unwilling to give your formal agreement to participate in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 585-275-5391

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06964464

Sponsor: University of Rochester

Phase: Phase 4

Status: Recruiting

Condition: Cardiomyopathy

Trial contact: 585-275-5391

More information: https://clinicaltrials.gov/study/NCT06964464

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You have an implanted defibrillator device (ICD) that was placed to prevent a first serious heart event, due to heart failure with reduced pumping ability, and your device can be monitored remotely
You are currently taking a heart medication called metoprolol succinate and are willing to switch to a different heart medication called carvedilol
A heart scan in the last 12 months has shown that your heart's pumping function is below 50%

Who may not be able to join:

You are unwilling or unable to follow the study requirements and schedule
You are currently taking a different beta-blocker heart medication other than metoprolol succinate, or you are not taking any beta-blocker medication at all
You have had a bad reaction to carvedilol in the past, or there is a medical reason why you cannot take it
Your blood pressure is too low (the lower number on a blood pressure reading is below 100) (confirm with trial site)
You are already taking part in another clinical trial
You are unable or unwilling to give your formal agreement to participate in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

University of Rochester

Registry

ClinicalTrials.gov

Start date

17 August 2025

Est. completion

1 June 2031

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Composite Endpoint: First Occurrence of ICD Therapy, Cardiovascular Hospitalization, or Cardiovascular Death

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov